Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Cellular and Molecular Gastroenterology and Hepatology
|
September 26, 2024
Rethinking Immune Check Point Inhibitors Use in Liver Transplantation: Implications and Resistance
Vivian Ortiz, Emilien Loeuillard
Cellular and Molecular Gastroenterology and Hepatology
|
July 9, 2021
MEK Inhibition: A New Ally in Immunotherapy for Intrahepatic Cholangiocarcinoma
Emilien Loeuillard, Gregory J Gores, Sumera I Ilyas
Expert Opinion on Therapeutic Targets
|
November 22, 2021
Cholangiocarcinoma: what are the most valuable therapeutic targets - cancer-associated fibroblasts, immune cells, or beyond T cells?
Juan Wang, Emilien Loeuillard, Gregory J Gores, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
April 9, 2018
Animal models of cholangiocarcinoma
Emilien Loeuillard, Samantha R Fischbach, Gregory J Gores, et al.
JHEP Reports : Innovation in Hepatology
|
February 11, 2020
Immunobiology of cholangiocarcinoma
Emilien Loeuillard, Caitlin B Conboy, Gregory J Gores, et al.
Frontiers in Physiology
|
April 12, 2016
Culture Model of Rat Portal Myofibroblasts
Haquima El Mourabit, Emilien Loeuillard, Sara Lemoinne, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
October 8, 2018
Endoplasmic reticulum stress induces inverse regulations of major functions in portal myofibroblasts during liver fibrosis progression
Emilien Loeuillard, Haquima El Mourabit, Lin Lei, et al.
World Journal of Gastroenterology
|
January 7, 2015
2,4,6-trinitrobenzene sulfonic acid-induced chronic colitis with fibrosis and modulation of TGF-β1 signaling
Emilien Loeuillard, Julien Bertrand, Anni Herranen, et al.
Plos One
|
July 8, 2014
Magnetic resonance colonography for fibrosis assessment in rats with chronic colitis
Chloé Melchior, Emilien Loeuillard, Rachel Marion-Letellier, et al.
The Journal of Clinical Investigation
|
July 15, 2020
Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma
Emilien Loeuillard, Jingchun Yang, EeeLN Buckarma, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Cellular and Molecular Gastroenterology and Hepatology
|
September 26, 2024
Rethinking Immune Check Point Inhibitors Use in Liver Transplantation: Implications and Resistance
Vivian Ortiz, Emilien Loeuillard
Cellular and Molecular Gastroenterology and Hepatology
|
July 9, 2021
MEK Inhibition: A New Ally in Immunotherapy for Intrahepatic Cholangiocarcinoma
Emilien Loeuillard, Gregory J Gores, Sumera I Ilyas
Expert Opinion on Therapeutic Targets
|
November 22, 2021
Cholangiocarcinoma: what are the most valuable therapeutic targets - cancer-associated fibroblasts, immune cells, or beyond T cells?
Juan Wang, Emilien Loeuillard, Gregory J Gores, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
April 9, 2018
Animal models of cholangiocarcinoma
Emilien Loeuillard, Samantha R Fischbach, Gregory J Gores, et al.
JHEP Reports : Innovation in Hepatology
|
February 11, 2020
Immunobiology of cholangiocarcinoma
Emilien Loeuillard, Caitlin B Conboy, Gregory J Gores, et al.
Frontiers in Physiology
|
April 12, 2016
Culture Model of Rat Portal Myofibroblasts
Haquima El Mourabit, Emilien Loeuillard, Sara Lemoinne, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
October 8, 2018
Endoplasmic reticulum stress induces inverse regulations of major functions in portal myofibroblasts during liver fibrosis progression
Emilien Loeuillard, Haquima El Mourabit, Lin Lei, et al.
World Journal of Gastroenterology
|
January 7, 2015
2,4,6-trinitrobenzene sulfonic acid-induced chronic colitis with fibrosis and modulation of TGF-β1 signaling
Emilien Loeuillard, Julien Bertrand, Anni Herranen, et al.
Plos One
|
July 8, 2014
Magnetic resonance colonography for fibrosis assessment in rats with chronic colitis
Chloé Melchior, Emilien Loeuillard, Rachel Marion-Letellier, et al.
The Journal of Clinical Investigation
|
July 15, 2020
Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma
Emilien Loeuillard, Jingchun Yang, EeeLN Buckarma, et al.
Page
of 2